| 发明名称 | 2-(pyridin-2YL)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulator | ||
| 摘要 | The invention relates to spiro derivative of formula (I), to the use of said derivative in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivative and processes for its preparation.; | ||
| 申请公布号 | US9303032(B2) | 申请公布日期 | 2016.04.05 |
| 申请号 | US201214365391 | 申请日期 | 2012.12.21 |
| 申请人 | Convergence Pharmaceuticals Limited | 发明人 | Witty David R.;MacPherson David T.;Giblin Gerard M. P.;Stanway Steven J. |
| 分类号 | C07D487/10;C07D471/10 | 主分类号 | C07D487/10 |
| 代理机构 | Honigman Miller Schwartz and Cohn LLP | 代理人 | Honigman Miller Schwartz and Cohn LLP ;Doyle Kathryn D.;O'Brien Jonathan P. |
| 主权项 | 1. A compound of formula (I) which is 7-methyl-2-[4-[3-(trifluoromethoxy)phenyl]-2-pyridyl]-1,7-diazaspiro[4.4]nonan-6-one:or a pharmaceutically acceptable salt thereof. | ||
| 地址 | London GB | ||